1De Silva LD, Kumar A, Sathian B. The significance of lipid profile and positive troponin in predicting cardiac event[J]. Kathmandu Univ Med J, 2009, 7(27) : 263-267.
2Kumar A, Nagtilak S, Sivakanesan R, et al. Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients-a case controlled study from india [J]. Southeast Asian J Trop Med Public Health, 2009, 40(3) : 581-592.
3Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care [J]. Eur Heart J, 2010,31(18):2197- 2204.
4Piers LH, Salachova F, Slart RH, et al. The role of coronary artery calcification score in clinical practice [J]. BMC Cardiovasc Disord, 2008, 8:38.
5Kumar A, Sivakanesan R, Gunasekera S. Oxidative stress and antioxidant status in normolipidemic AMI patients[J] . Indian J Clin Biochem, 2008, 23(3) :296-298.
6Gude D, Byrapaneni RB. Isehaemia modified albumin.. Does it bolster our diagnostic ammunition? [J]. Indian J Anaesth, 2011,55(4) :408-411.
7Van Belie E, Dallongeville J, Vieaut E, et al. Ischemia- modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study[J] . Am Heart J, 2010, 159(4):570-576.
8McDonnell B, Hearty S, Leonard P, et al. Cardiac biomarkers and the case for point-of-care testing[J] . Clin Biochem, 2009, 42(7 8) :549-561.
9Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co^2+ and Ni^2 + binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia [J] . Eur J Biochem, 2001, 268(1) :42- 47.
10Sinha MK, Roy D, Gaze DC, et al. Role of "Ischemia modified albumin ", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes[J] . EmergMedJ, 2004, 21(1): 29-34.
3[1]Gibbons RJ,Abrams J,Gary J,et al.ACC/AHA guidelines for exercise testing:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on Exercise Testing)[J].J Am Coll Cardiol,1997,30(6):260-311
4[2]Defilippi IC,Yoon S,Ro A,et al.Early detection of myocardial ischemia by a novel blood based biomarker:the kinetics of ischemia modified albumin[J].JACC,2003,41(SupplA):A340
5[3]Sinha MK,Gaze DC,Tippins JR,et al.Ischemia modified albumin is a sensitive marker of myocardial ischemia after precutaneous coronary intervention[J].Circulation,2003,107(19):2403-2407
6[4]French JK,White HD.Clinical implications of the definition of myocardial infarction[J].Heart,2004,90(1):99-106
7[5]Falkensammer J,Stojakovic T,Huber K,et al.Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia[J].Clin Chem Lab Med,2007,45(4):535-540
8[6]Abboud H,Labreuche J,Meseguer E,et al.Ischemia-modified albumin in acute stroke[J].Cerebrovasc Dis,2007,23(2-3):216-220
9[7]Nihat K,Vakup C,Emrullah B,et al.Use of ischema-modified albumin in diagnosis of coronary artery disease[J].Coron Artery Dis,2007,18(8):633-637
10[8]Sharouni E,Georgiadou P,Theodorakis GN,et al.Ischemia-modified albumin in relation to exercise stress testing[J].J Am Coll Cardiol,2006,48(3):2482-2484
3Ferguson JF. Hinkle CC, Mehta NN, et al. Translational studies of lipoprotein-associated phospholipase A2 in inflammation and atherosclerosis[J]. J Am Coll Cardiol, 2012, 59(8): 764-772.
4Gilstrap LG, Wang TJ. Biomarkers and cardiovascular risk as- sessment for primary prevention: an update [J]. Clin Chem, 2012, 58(1): 72-82.
5Oei HH, van der Meer IM, Hofman A. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study [J]. Circulation, 2005, 111(5): 570-575.
6Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co (2+) and Ni (2+)binding aminoacid residues of the N-ter- minus of human albumin[J]. Eur J Biochem, 2001, 268(1): 42-47.
7Abboud H, Labreuche J, Meseguer E, et al. Ischemia modified albumin in acute stroke[J]. Cerebrovasc Dis, 2007, 23: 216-218.
8Rubinstein A, Izkhakav E. Lipoprotein associated phospholipase A2[J]. Harefuah, 2011, 150(2): 136-140, 205.
9Tellis CC, Tselepis AD. The role of lipoprotein associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma [J]. Biochim Biophys Acta, 2009, 1791 (5): 327-338.
10Nambi V, Hoogeveen RC, Chambless L, et al. Lipoprotein- associated phospholipase A2 and high-sensitivity C-reactive pro- tein improve the stratification of ischemie stroke risk in the Atherosclerosis Risk in Communities (ARIC) study[J]. Stroke, 2009, 40(2): 376-381.
